A detailed history of Centerpoint Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Centerpoint Advisors, LLC holds 1,245 shares of ABT stock, worth $148,092. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,245
Previous 1,167 6.68%
Holding current value
$148,092
Previous $121,000 17.36%
% of portfolio
0.05%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$100.07 - $118.13 $7,805 - $9,214
78 Added 6.68%
1,245 $142,000
Q2 2024

Jul 30, 2024

BUY
$100.73 - $112.44 $30,521 - $34,069
303 Added 35.07%
1,167 $121,000
Q4 2023

Jan 16, 2024

SELL
$90.19 - $110.4 $50,686 - $62,044
-562 Reduced 39.41%
864 $95,000
Q2 2023

Jul 17, 2023

SELL
$100.78 - $112.29 $10,279 - $11,453
-102 Reduced 6.68%
1,426 $155,000
Q1 2023

May 03, 2023

BUY
$96.86 - $114.01 $12,979 - $15,277
134 Added 9.61%
1,528 $155,000
Q1 2022

Apr 27, 2022

BUY
$114.02 - $139.04 $60,430 - $73,691
530 Added 61.34%
1,394 $165,000
Q3 2021

Oct 25, 2021

SELL
$116.66 - $129.06 $7,816 - $8,647
-67 Reduced 7.2%
864 $102,000
Q2 2021

Jul 26, 2021

BUY
$105.79 - $124.53 $7,087 - $8,343
67 Added 7.75%
931 $108,000
Q1 2021

Apr 23, 2021

BUY
$108.84 - $128.23 $94,037 - $110,790
864 New
864 $104,000
Q4 2018

Feb 05, 2019

SELL
$65.56 - $74.27 $41,171 - $46,641
-628 Closed
0 $0
Q3 2018

Nov 08, 2018

BUY
$60.81 - $73.36 $38,188 - $46,070
628 New
628 $46,000
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $24,639 - $27,195
-428 Closed
0 $0
Q1 2018

May 09, 2018

BUY
$56.27 - $63.62 $24,083 - $27,229
428 New
428 $26,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Centerpoint Advisors, LLC Portfolio

Follow Centerpoint Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centerpoint Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centerpoint Advisors, LLC with notifications on news.